Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",49869,300,1.36 [0.99-1.88],0.0565185837007977
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",51675,399,1.14 [0.86-1.50],0.3680283535517568
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",51143,2781,1.07 [0.96-1.19],0.1999081651253313
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Candidiasis,51714,862,0.94 [0.78-1.14],0.548592653451381
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,50155,7058,1.04 [0.97-1.11],0.2938006859098178
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),50342,6439,1.11 [1.04-1.19],0.0030791280959623
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,51203,2443,1.12 [1.00-1.26],0.0431781416585143
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,51525,172,1.47 [0.97-2.25],0.07188405569172
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,47588,1964,1.07 [0.94-1.21],0.3024544839755517
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,45972,2226,1.22 [1.09-1.38],0.0009020470785993
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,45712,518,1.20 [0.94-1.53],0.1514127154254722
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,36327,3995,1.04 [0.95-1.14],0.3892935488607448
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,45405,790,1.54 [1.26-1.88],2.144760107940784e-05
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,51643,2883,1.11 [1.00-1.23],0.0477395613785546
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Mycoses,51872,1020,0.98 [0.82-1.17],0.8231937943653469
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,50227,1865,1.09 [0.95-1.24],0.2103503907158418
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,51735,2166,1.07 [0.95-1.21],0.2494593270231773
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,49161,401,1.11 [0.84-1.47],0.4500209803198046
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,51973,100,1.79 [1.03-3.10],0.0388552030459398
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other septicaemia,51464,1895,1.04 [0.92-1.18],0.5307399039665499
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,51509,156,0.94 [0.60-1.46],0.7762679594763854
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other viral diseases,51810,317,1.51 [1.10-2.06],0.0101384217617548
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",51773,280,1.53 [1.10-2.14],0.0121930812827086
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,49209,847,1.01 [0.84-1.23],0.8870130318225508
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,48920,558,1.14 [0.90-1.45],0.2626448610677365
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,48983,223,1.35 [0.93-1.96],0.1125495592236859
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,51930,105,1.16 [0.68-1.98],0.5870532739325836
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,51841,309,1.01 [0.73-1.39],0.9591650216860548
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Viral warts,51633,101,1.60 [0.92-2.77],0.0939343043519578
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],51664,132,0.67 [0.41-1.09],0.1104102808573223
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm,51378,589,0.80 [0.63-1.00],0.0544279846306626
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,51795,116,0.52 [0.31-0.87],0.0136567141250777
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,51756,126,0.94 [0.57-1.54],0.7954272296001337
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23896,129,0.85 [0.52-1.38],0.5103634763755309
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",51302,2899,0.79 [0.71-0.87],6.106922652493443e-06
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm of meninges,51945,113,0.86 [0.50-1.46],0.5675153896469131
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,51840,129,1.12 [0.68-1.82],0.6614185754390303
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,51923,212,1.15 [0.79-1.69],0.4599332155765093
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm of ovary,27943,181,0.89 [0.58-1.36],0.5956975240477589
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Ascending colon,51926,730,0.79 [0.65-0.98],0.0286875669535656
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Caecum,51927,598,0.82 [0.65-1.03],0.082950646190705
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",51751,148,1.18 [0.75-1.85],0.4814197172658916
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Descending colon,51922,436,0.60 [0.46-0.79],0.000196127634793
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Rectum,51841,706,0.77 [0.62-0.95],0.0134072816382766
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,51740,1241,0.76 [0.65-0.89],0.0006948211273692
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Transverse colon,51909,867,0.70 [0.58-0.84],0.00016389751203
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Carcinoma in situ of breast,22715,138,0.73 [0.45-1.19],0.2071811736842745
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",22808,168,0.60 [0.39-0.94],0.025051021961374
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",41382,103,1.53 [0.89-2.64],0.1263981661276725
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",41418,139,0.80 [0.49-1.28],0.3473382098090923
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",51873,238,0.78 [0.54-1.13],0.1891170739206724
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Haemangioma, any site",51874,233,0.78 [0.54-1.13],0.1921544692084859
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Leiomyoma of uterus,27016,598,0.85 [0.68-1.08],0.1862310100572723
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Lung cancer and mesothelioma,36036,664,0.53 [0.43-0.65],6.0023383132530084e-09
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Lymphoid leukaemia,41382,103,1.26 [0.72-2.18],0.4186061975172613
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",41660,381,1.16 [0.86-1.54],0.3288794249058644
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",41689,410,0.94 [0.72-1.24],0.6816139475656509
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",22944,191,1.28 [0.85-1.94],0.2364150485149389
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",41438,159,1.23 [0.79-1.91],0.3536282500868877
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",41494,215,1.07 [0.73-1.56],0.727276863341735
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",41475,196,0.87 [0.59-1.29],0.4908766961839712
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",22898,145,1.69 [1.05-2.71],0.0312743653456445
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",41464,185,1.16 [0.77-1.75],0.4865240849860131
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",19932,1406,1.01 [0.87-1.17],0.9236278127326792
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",41509,230,1.22 [0.84-1.77],0.2879663855024605
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",41428,149,1.10 [0.70-1.74],0.6700732983724076
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,41490,211,1.07 [0.73-1.58],0.7332906444176013
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Melanocytic naevi,51580,406,0.85 [0.64-1.12],0.2543538929738741
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Melanocytic naevi of trunk,51894,175,0.63 [0.41-0.96],0.0305845116399169
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Melanoma in situ,41349,165,0.77 [0.49-1.20],0.2442876684293259
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",41462,183,0.80 [0.53-1.21],0.2950983715280218
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",41603,324,0.87 [0.64-1.20],0.4013884422642085
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",41729,450,0.50 [0.38-0.65],1.947852283861318e-07
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",41476,197,0.99 [0.66-1.48],0.9656467422754696
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Other benign neoplasms of skin,51612,310,0.84 [0.61-1.16],0.2855796163752965
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",43455,2176,1.03 [0.91-1.16],0.6180289403920289
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",43573,2294,1.04 [0.92-1.17],0.527135251198149
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,51383,691,0.83 [0.67-1.02],0.077828812917225
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,48166,224,5.72 [3.99-8.19],2.088170090681297e-21
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,50836,144,1.01 [0.63-1.60],0.9789190398730672
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,50377,5842,1.10 [1.03-1.19],0.0083760608930771
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,49009,98,1.53 [0.88-2.67],0.1318284597036249
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,51130,103,0.77 [0.44-1.32],0.3399901431251478
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,50999,3057,1.17 [1.06-1.29],0.0023309829454969
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,50997,3055,1.17 [1.06-1.30],0.0020526012502893
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,48118,176,1.69 [1.11-2.57],0.0141740554176472
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,51316,2405,1.21 [1.08-1.36],0.0008050522822946
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,51257,230,1.46 [1.01-2.11],0.0437452705204673
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,50822,130,0.85 [0.52-1.38],0.5022767644604074
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,50811,119,1.25 [0.75-2.08],0.3936215053302527
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,51589,562,1.16 [0.92-1.47],0.2129465145608613
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,51761,112,1.01 [0.59-1.71],0.977551483136954
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",51491,464,1.21 [0.94-1.57],0.1461838328544692
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,49125,214,0.77 [0.52-1.12],0.1720918413794303
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,40201,635,1.15 [0.92-1.44],0.2101872735494848
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,48470,233,0.37 [0.25-0.53],5.789647185356601e-08
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,48496,259,0.52 [0.40-0.66],1.1689947185630345e-07
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,39677,111,0.50 [0.29-0.85],0.0107849214824083
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,48275,137,1.04 [0.65-1.67],0.8643616045988171
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,47129,471,0.74 [0.57-0.96],0.0232502810435961
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",51019,1135,1.17 [0.99-1.38],0.0641841002674614
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,50418,534,1.25 [0.98-1.60],0.0674091352023233
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,50140,256,0.87 [0.61-1.23],0.4297767535078047
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,51265,3127,0.85 [0.76-0.93],0.00103111547107
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,45289,3033,0.81 [0.74-0.90],8.898867915405545e-05
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",39701,135,0.88 [0.54-1.44],0.6195327920076156
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",47915,160,1.12 [0.72-1.75],0.6179977219247899
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,40129,563,1.24 [0.97-1.57],0.0807495573373445
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,39689,123,0.95 [0.57-1.59],0.8501775865011759
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,46684,7118,0.83 [0.77-0.88],2.724436502298645e-08
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,39955,389,0.80 [0.60-1.07],0.1392782276307241
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,40683,1117,0.99 [0.84-1.18],0.92932289200303
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,51807,653,1.55 [1.25-1.93],7.551878273129122e-05
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,51429,275,3.22 [2.32-4.46],2.055618959248623e-12
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,39821,255,0.95 [0.67-1.35],0.774733712147719
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",39688,122,1.97 [1.18-3.27],0.0091008888879375
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,50880,3125,1.12 [1.02-1.24],0.0230609571541686
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,40087,521,1.62 [1.27-2.06],0.0001109582875582
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,40163,597,1.96 [1.56-2.46],5.600621554231164e-09
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",40837,1271,0.94 [0.80-1.10],0.4138197340889383
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,39808,242,1.17 [0.82-1.68],0.3880328120850941
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,51412,258,3.48 [2.49-4.87],2.7818315766444773e-13
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,40774,1208,0.94 [0.80-1.11],0.4618903954988541
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,40532,966,0.71 [0.59-0.85],0.00019597354756
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,46796,138,2.03 [1.27-3.24],0.0032636075437993
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,49600,10034,0.88 [0.83-0.93],6.207223826469997e-06
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,47853,98,1.52 [0.86-2.67],0.1509931165129515
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,47866,111,0.86 [0.50-1.48],0.592094963777287
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,51599,3912,0.87 [0.80-0.95],0.0022894664972705
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",51601,3907,0.87 [0.80-0.95],0.0019798566918473
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,47860,105,1.27 [0.74-2.20],0.3892708721742414
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,51283,2424,0.82 [0.73-0.91],0.0004778237257295
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",42744,3178,1.01 [0.92-1.12],0.7702790542830033
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,51947,453,2.72 [2.12-3.49],4.0528932453419385e-15
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,50052,168,1.12 [0.73-1.71],0.6161537364672018
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,49070,211,0.95 [0.65-1.40],0.7914153225343455
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,49144,285,0.82 [0.59-1.15],0.2554354218401559
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",39903,337,1.06 [0.77-1.45],0.721918717501435
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,47299,310,2.32 [1.70-3.17],1.31826851468569e-07
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,4264,173,1.61 [1.08-2.38],0.0186712045096835
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,4541,507,1.61 [1.28-2.03],4.313759512422086e-05
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,47117,128,1.48 [0.90-2.43],0.118906995950348
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,4201,113,7.38 [4.64-11.75],3.3580109220417085e-17
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,50687,3698,1.00 [0.91-1.10],0.9949412237688664
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,50591,707,0.97 [0.78-1.19],0.7588238657535399
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,47390,732,1.05 [0.85-1.29],0.6610604732974465
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,41114,1548,1.28 [1.11-1.48],0.0007134775882789
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",51745,487,1.62 [1.26-2.08],0.0001599149913122
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),49706,323,0.91 [0.67-1.24],0.5396763223551655
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Angina pectoris,47475,2406,0.89 [0.80-1.00],0.0505775931141648
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Aortic aneurysm,49860,477,0.85 [0.66-1.10],0.221279420855543
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,49503,120,1.20 [0.73-1.99],0.4706842936423041
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",49782,399,1.07 [0.81-1.41],0.621179142522639
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,32256,3838,0.89 [0.82-0.98],0.01822665102238
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,AV-block,43784,865,0.97 [0.80-1.18],0.7921996615794029
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",51854,850,1.33 [1.10-1.61],0.0032835606644788
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Cardiac arrest,28802,384,1.19 [0.89-1.61],0.2399395361240678
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Cardiomyopathy,43255,336,0.72 [0.53-0.97],0.0337837319817137
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",43106,187,0.81 [0.54-1.23],0.3209691561600045
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,51970,100,0.69 [0.40-1.19],0.1798136854203335
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Conduction disorders,45028,2109,0.99 [0.87-1.12],0.8313824797946764
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,49210,4176,0.92 [0.84-1.00],0.0495773212467547
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,45355,15203,0.87 [0.83-0.91],1.0952571703041008e-09
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,DVT of lower extremities,49180,526,1.59 [1.25-2.03],0.0001486801443686
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Endocarditis,43066,147,1.16 [0.73-1.85],0.5321657124027563
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Heart failure, strict",51558,2213,0.93 [0.82-1.04],0.2152529708842108
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Hypertension,47203,13060,0.84 [0.80-0.89],2.841978495915468e-11
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Hypertension, essential",47239,13096,0.86 [0.82-0.90],9.148779260279499e-10
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Hypertension, portal",51625,156,1.29 [0.83-2.00],0.2520091414980235
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",34496,353,0.89 [0.67-1.20],0.4556792255791523
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,34415,272,13.31 [9.61-18.42],6.918412189518072e-55
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Hypotension,51682,2372,1.07 [0.96-1.20],0.2385550239248157
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,50120,216,0.89 [0.61-1.30],0.5368373246964337
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",49551,4482,0.90 [0.83-0.98],0.0153982939459298
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",51218,1126,0.96 [0.81-1.13],0.6375387835762645
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Left bundle-branch block,43646,727,1.00 [0.81-1.23],0.965747902845677
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,51002,1688,1.09 [0.95-1.24],0.2310079611014739
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",46495,1426,1.14 [0.99-1.32],0.0779100111645949
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",51785,312,1.18 [0.87-1.62],0.2916561208257863
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",51913,624,1.14 [0.91-1.43],0.241149050777811
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Oesophageal varices,48764,110,1.66 [0.99-2.80],0.0556417695840193
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other aneurysm,49538,155,0.98 [0.63-1.53],0.9278744543942884
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other arrhythmias,43773,854,1.03 [0.85-1.25],0.7444306433988053
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,49585,202,1.13 [0.77-1.67],0.5229511647867862
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,49867,484,1.11 [0.86-1.43],0.4258158988530179
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,43278,359,0.87 [0.64-1.17],0.3584259075439987
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other disorders of veins,48852,198,0.95 [0.64-1.41],0.810690625445759
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,48750,96,1.14 [0.65-2.01],0.6550638576568977
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,49097,131,0.60 [0.37-0.98],0.0414537277825806
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,48932,278,0.79 [0.56-1.10],0.1580018185933193
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,45003,2084,0.97 [0.86-1.10],0.666205729900688
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,49420,110,2.60 [1.55-4.37],0.0002902395716394
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,50471,1088,1.02 [0.87-1.21],0.7811820569587987
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,50735,693,0.85 [0.69-1.05],0.1297647736518085
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",50195,1229,1.01 [0.86-1.18],0.9226123206636936
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,29093,675,0.85 [0.68-1.06],0.1444388134192812
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Peripheral artery disease,50129,809,1.03 [0.85-1.25],0.7525553595863348
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),49343,689,1.52 [1.23-1.88],0.000105934075681
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Pulmonary embolism,50997,955,1.12 [0.93-1.34],0.2290435862663917
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,51829,1319,0.96 [0.82-1.12],0.6026477277332021
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Right bundle-branch block,43617,698,1.02 [0.82-1.26],0.8872019005701961
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Secondary right heart disease,50724,682,0.84 [0.68-1.04],0.1041059960706152
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,49354,388,0.85 [0.64-1.12],0.2486397307092623
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",51195,1291,0.95 [0.81-1.11],0.4906979281921145
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",51154,1369,1.00 [0.86-1.16],0.9492043596291964
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,50063,120,1.37 [0.82-2.28],0.2307389531271426
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,49545,163,1.02 [0.66-1.59],0.9139135548915616
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Transient ischemic attack,50566,474,0.94 [0.73-1.22],0.6563455730051164
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,49837,523,0.92 [0.72-1.17],0.4896502112280271
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Varicose veins,49506,852,1.11 [0.91-1.34],0.3053118642258208
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,49410,172,0.97 [0.63-1.49],0.8806424327949929
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Venous thromboembolism,51516,1504,1.29 [1.12-1.49],0.000447982613542
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",51729,721,0.44 [0.36-0.54],7.667044235247054e-15
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",45474,2861,0.81 [0.73-0.91],0.0001501935756637
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Any mental disorder,50661,8048,0.84 [0.79-0.90],1.110123177898933e-07
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",51634,852,0.42 [0.35-0.51],2.400851663197208e-19
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",45800,3187,0.83 [0.75-0.92],0.0002183486715
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",42793,180,0.73 [0.48-1.10],0.1348456602336157
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Smoking dependency,50900,2754,0.78 [0.71-0.87],6.27832633698348e-06
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",45892,3279,0.73 [0.66-0.81],4.2972584354062605e-10
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Vascular dementia,50945,254,1.19 [0.84-1.68],0.3366034471676015
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Alzheimer disease,51972,664,1.19 [0.96-1.48],0.1208341520582831
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",35050,118,2.31 [1.39-3.84],0.0011795453303146
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Bell's palsy,48394,160,0.83 [0.54-1.29],0.4159979434470164
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,49226,992,1.07 [0.90-1.28],0.4374967993631133
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Cerebral cysts,51148,463,0.93 [0.72-1.21],0.6036716316161952
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,51812,652,0.68 [0.55-0.84],0.0005014784346596
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,50962,99,0.89 [0.51-1.56],0.6873847806262223
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,51938,120,1.08 [0.65-1.80],0.7534846885805255
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",50834,149,0.62 [0.39-0.97],0.0372643911050242
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Epilepsy,48830,576,0.87 [0.69-1.10],0.251908219675916
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,51008,2754,0.93 [0.84-1.04],0.1919998534421293
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,51889,1212,0.90 [0.77-1.06],0.1967117219641393
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Falls/tendency to fall,50770,5180,0.95 [0.88-1.03],0.2027642570018722
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Generalized epilepsy,51202,108,1.00 [0.59-1.72],0.987741581024354
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Hemiplegia,51669,509,0.78 [0.61-0.99],0.0450877934978178
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Hydrocephalus,50809,124,0.86 [0.52-1.42],0.558586731274362
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,51935,140,0.93 [0.58-1.50],0.7720714141906091
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,48384,150,0.99 [0.62-1.58],0.9804604684697688
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,48395,161,0.57 [0.37-0.88],0.0110051904944386
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Memory loss,50654,219,0.91 [0.62-1.32],0.6097081712182287
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Migraine,48975,721,0.98 [0.79-1.21],0.8385647524998442
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",51831,649,0.98 [0.78-1.22],0.8567765839990427
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Motor neuron disease,35248,276,0.76 [0.54-1.07],0.1153120688307005
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,51634,209,0.76 [0.52-1.13],0.1781667521249871
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",50637,2403,0.99 [0.88-1.11],0.8661073404048131
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Neurological diseases,49003,7577,0.95 [0.89-1.02],0.1514107422143137
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,51269,406,0.87 [0.66-1.15],0.3359984895877216
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",49057,823,1.02 [0.84-1.24],0.813693376443686
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",51818,595,1.60 [1.27-2.00],4.8414353791516775e-05
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,41356,1304,1.00 [0.85-1.17],0.990625892665141
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,50833,148,1.23 [0.78-1.93],0.3837049954710783
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other disorders of nervous system,50968,283,1.28 [0.93-1.78],0.1344769882520958
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,51007,330,1.02 [0.75-1.38],0.9205225603402192
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other facial nerve disorders,48424,190,0.91 [0.61-1.36],0.6428081935103297
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other headache syndromes,48369,115,0.94 [0.56-1.59],0.8261767403702338
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other neurological diseases,51729,1044,0.96 [0.81-1.14],0.6274373016393997
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other sleep disorders,49375,1121,0.93 [0.79-1.10],0.4211179059123632
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Parkinson's disease,51926,855,0.86 [0.71-1.04],0.125660921240389
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,50796,111,0.98 [0.57-1.68],0.9404173559449616
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Restless leg syndrome,51971,157,1.24 [0.79-1.94],0.3440451883605276
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Sleep apnoea,51488,964,0.88 [0.74-1.05],0.1680824240217642
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Small fibre neuropathy,51322,99,1.12 [0.64-1.97],0.6829283184775443
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,51944,331,0.74 [0.54-1.00],0.0531956163179484
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,48337,103,0.66 [0.38-1.15],0.1407719948146934
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,51972,671,1.19 [0.96-1.48],0.108294030146994
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),50870,247,1.20 [0.84-1.71],0.3141764953730482
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,50823,197,0.72 [0.48-1.07],0.1031073463457069
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,51146,800,0.98 [0.80-1.20],0.8350987013993895
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,51623,468,1.79 [1.40-2.30],4.6515596956764935e-06
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,49956,107,0.54 [0.31-0.93],0.0250501055775573
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,49965,116,1.11 [0.66-1.87],0.6928977666825441
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",51753,104,0.82 [0.47-1.41],0.4740455798561379
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,51445,295,1.09 [0.78-1.50],0.6228259791228421
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",4212,121,6.75 [4.31-10.58],8.309816188706598e-17
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,5102,204,1.81 [1.27-2.57],0.0010748547408891
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,50815,189,0.98 [0.66-1.48],0.9386945101693476
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,51536,2076,1.11 [0.98-1.26],0.0948763803675247
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",51236,1387,0.96 [0.83-1.11],0.5886555467960393
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,50296,447,1.00 [0.76-1.30],0.9741856586306818
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",51802,1456,1.03 [0.89-1.20],0.676553940043158
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,51953,138,1.30 [0.81-2.08],0.2828423148451526
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,51652,1306,1.03 [0.88-1.20],0.7133572274082
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",51884,734,1.00 [0.81-1.23],0.9773700512778352
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,51784,360,0.96 [0.71-1.29],0.7770793442197049
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,49966,117,0.90 [0.54-1.51],0.6944608669436101
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,49984,135,0.89 [0.55-1.43],0.6246574922069139
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,49960,111,0.95 [0.55-1.61],0.8361442166013017
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,51784,1415,1.02 [0.88-1.18],0.823196518585018
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,50737,368,1.18 [0.89-1.58],0.2519468598229212
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,50443,97,1.12 [0.63-1.98],0.6944015583975051
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,51349,199,0.87 [0.59-1.29],0.4955728743704091
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,51701,551,1.07 [0.84-1.36],0.5813026825482897
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,50736,390,1.09 [0.82-1.45],0.5440313701523622
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,51644,220,0.89 [0.61-1.30],0.5418642886080978
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,51314,945,1.04 [0.87-1.25],0.6425174803054081
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,50907,281,0.84 [0.60-1.17],0.3021367683557257
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,48754,4376,1.02 [0.94-1.11],0.6566955799774137
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,51628,478,1.05 [0.81-1.36],0.7134304982173227
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,51930,307,1.26 [0.92-1.73],0.1515097304885335
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,50669,820,0.94 [0.77-1.14],0.5404941806814337
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,51278,128,1.00 [0.61-1.63],0.993970462302638
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,51927,112,1.54 [0.91-2.60],0.1042974873238297
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,50020,171,0.93 [0.61-1.42],0.7331543566769538
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,50146,297,0.89 [0.65-1.24],0.4959319976281887
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,49697,237,0.92 [0.64-1.32],0.6539181378111026
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,50470,124,1.12 [0.68-1.85],0.6609546419976334
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",49587,127,0.51 [0.31-0.84],0.008311049091309
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,50544,175,0.81 [0.53-1.24],0.3332047433083523
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",50759,390,1.24 [0.94-1.64],0.1327023310823445
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,50105,256,1.02 [0.72-1.45],0.9015347397191584
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,49681,221,0.75 [0.51-1.10],0.14316453376575
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,49631,171,0.98 [0.64-1.50],0.9252834719144564
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,48003,3625,0.98 [0.89-1.07],0.6293643084327747
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,49994,145,0.86 [0.54-1.37],0.530722295552827
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,51452,826,0.86 [0.70-1.04],0.1152859790374147
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,50746,120,0.83 [0.50-1.38],0.4799994556038147
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),50968,342,1.08 [0.80-1.46],0.5983362321245591
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,51546,177,1.17 [0.76-1.78],0.4772532309812275
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,51881,240,1.15 [0.80-1.65],0.4393774774278101
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,51707,263,0.95 [0.67-1.34],0.7698695256576114
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,51489,120,1.76 [1.06-2.92],0.0288414973755636
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,51495,126,1.33 [0.81-2.19],0.2641854994959453
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,51777,1807,0.96 [0.84-1.09],0.5403153729727439
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,51261,1291,0.93 [0.79-1.08],0.3297799638067282
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,50225,255,1.12 [0.79-1.58],0.5361262966090443
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,50143,173,1.11 [0.73-1.70],0.6280005099506869
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Acute pharyngitis,51482,149,0.88 [0.55-1.39],0.5693563475018542
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,51761,428,1.05 [0.80-1.38],0.717847715566783
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,51462,129,1.42 [0.87-2.31],0.1615127471687087
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,All influenza,47900,239,1.50 [1.04-2.16],0.0284402601931525
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),47895,234,1.48 [1.03-2.14],0.0347009028008037
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Allergic asthma (mode),35607,235,0.83 [0.57-1.20],0.3191503287817937
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Allergic rhinitis,51706,560,0.80 [0.63-1.02],0.0724358599708394
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",38389,3559,0.84 [0.76-0.92],0.0002861227818196
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",38878,3506,0.84 [0.76-0.93],0.0004221651392526
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),51152,280,1.64 [1.18-2.28],0.0030912287025434
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",47826,165,1.35 [0.87-2.08],0.1768075066078577
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Bronchiectasis,45057,716,0.61 [0.49-0.75],3.214690306424538e-06
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",44458,117,0.93 [0.55-1.56],0.7715633227273857
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,49939,5598,0.81 [0.75-0.87],1.5904385540771372e-08
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",49214,141,0.73 [0.45-1.17],0.1865336296802134
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Chronic sinusitis,49382,309,0.62 [0.45-0.86],0.0036269320349302
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",51568,2391,0.71 [0.64-0.80],7.506064043942728e-09
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Deviated nasal septum,49285,212,0.71 [0.48-1.04],0.0812468530151782
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,47819,10578,0.86 [0.81-0.91],7.19384841149336e-08
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",49803,730,0.72 [0.59-0.89],0.0019817433607059
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Early onset COPD,49807,630,0.69 [0.55-0.86],0.0011088538900609
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Emphysema,44966,625,0.78 [0.62-0.97],0.0260719841171788
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,49363,571,0.78 [0.61-0.98],0.0337044689765312
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Influenza and pneumonia,51521,3860,0.93 [0.85-1.02],0.1189836369964594
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Interstitial lung disease,49433,641,0.77 [0.62-0.96],0.0219966601359615
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Later onset COPD,49961,1761,0.71 [0.62-0.81],2.712985207219739e-07
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,51946,660,0.95 [0.76-1.18],0.6228468777781755
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Nasal polyp,49288,215,0.88 [0.60-1.29],0.5151260611106174
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,51471,1953,1.00 [0.88-1.13],0.9978619147731752
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other diseases of pleura,51496,4003,0.88 [0.80-0.96],0.003236909177729
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,50746,1673,0.77 [0.68-0.89],0.0002618358682822
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other pleural conditions,47596,103,1.61 [0.93-2.78],0.0891623933593747
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,51792,801,0.93 [0.77-1.13],0.4777789860939677
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,51756,2606,0.87 [0.78-0.97],0.0106233591553779
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pleural effusion,49493,2000,0.95 [0.84-1.08],0.4502933653691277
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pleural plaque,47804,311,0.79 [0.58-1.09],0.1470874445320957
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",51015,3354,0.89 [0.81-0.98],0.0173828975578721
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,51816,530,1.07 [0.84-1.36],0.5745302511400806
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pneumothorax,47727,234,0.70 [0.49-1.02],0.060840649595734
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pollen allergy,51923,478,0.79 [0.61-1.02],0.0745577908683319
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pulmonary oedema,51122,131,1.89 [1.18-3.04],0.0084213243977335
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Respiratory insufficiency,35480,108,0.39 [0.23-0.66],0.0005667630228293
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,51427,1909,1.01 [0.89-1.14],0.9335146842903476
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,49635,562,0.80 [0.63-1.02],0.0662485035432062
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Viral pneumonia,48162,501,1.14 [0.89-1.47],0.2922449545695939
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",51181,413,1.23 [0.94-1.61],0.1378235477910598
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,23963,224,0.68 [0.46-0.99],0.0443878904826278
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,36726,130,1.10 [0.67-1.80],0.7038729064534774
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute appendicitis,51650,291,1.21 [0.87-1.69],0.250499640347643
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute gastritis,39100,180,1.42 [0.94-2.16],0.0984389848524594
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute pancreatitis,48263,369,0.95 [0.71-1.28],0.7517083186263629
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute peritonitis,51019,189,2.56 [1.72-3.80],3.3295189878690147e-06
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Alcoholic liver disease,50181,152,0.54 [0.34-0.84],0.0063128264538182
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Barrett oesophagus,39796,876,1.08 [0.89-1.30],0.4405374262322367
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",48095,201,1.22 [0.83-1.81],0.3105648382894371
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",51126,201,1.23 [0.83-1.81],0.2985368059508552
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Cholecystitis,48306,412,1.06 [0.80-1.39],0.696613763377027
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Cholelithiasis,49888,1994,0.96 [0.85-1.09],0.5149314589886883
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Chronic gastritis,39534,614,1.05 [0.83-1.31],0.692850312270963
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Chronic pancreatitis,47993,99,0.89 [0.51-1.56],0.6839967224114913
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",51679,210,1.24 [0.85-1.80],0.2668625089324583
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Coeliac disease,48735,250,0.99 [0.69-1.42],0.9623602838303716
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Collagenous colitis,48587,166,1.33 [0.86-2.06],0.2046847846512868
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,51666,374,0.92 [0.69-1.22],0.549171675548451
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Constipation,51455,3361,0.99 [0.90-1.09],0.8458539838244941
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Crohn disease,48607,186,1.53 [1.01-2.30],0.0425297391353003
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",51259,136,1.27 [0.78-2.04],0.3337423212587997
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Crohn's disease NAS,48597,176,2.00 [1.32-3.05],0.0011815161536214
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Dental caries,50475,459,1.12 [0.87-1.46],0.3825403287326102
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,46644,4483,0.94 [0.86-1.02],0.1428667075566937
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of appendix,51725,366,1.18 [0.88-1.58],0.2742280697825142
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of liver,51727,1698,0.88 [0.77-1.01],0.0740724774378445
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",47624,8704,0.96 [0.91-1.02],0.2018130168666737
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",51127,1111,1.12 [0.95-1.32],0.1925374223403948
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of peritoneum,51794,964,1.05 [0.87-1.25],0.6155176129843227
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,50246,230,1.27 [0.88-1.83],0.2021535523833716
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of salivary glands,49947,129,0.73 [0.44-1.19],0.2013354449580111
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of the digestive system,51340,2855,0.97 [0.87-1.08],0.5500532255172954
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of tongue,49981,222,1.64 [1.13-2.38],0.0097882571142359
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",50711,2817,0.98 [0.89-1.09],0.7552759594446979
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,42942,6346,0.88 [0.82-0.94],0.0002609632344585
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Duodenal ulcer,39321,401,0.96 [0.72-1.26],0.7517254783518601
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",51804,323,0.86 [0.64-1.18],0.3531129803536201
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,51790,112,1.13 [0.66-1.92],0.6654796967103132
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,50283,254,1.21 [0.86-1.71],0.2726843740130772
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,36891,295,1.06 [0.77-1.47],0.7107299416236555
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Functional dyspepsia,40022,1102,0.95 [0.80-1.13],0.5574046661623933
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastric ulcer,39642,722,0.96 [0.78-1.18],0.7080564016089566
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,43945,5025,0.88 [0.82-0.96],0.0026196353830792
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,39999,1079,0.92 [0.78-1.09],0.344032556955719
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,40239,16680,0.94 [0.90-0.99],0.0102366591246457
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,GI-bleeding,50822,2337,0.94 [0.84-1.05],0.2778628901593231
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,50122,106,0.60 [0.35-1.03],0.0642123065954325
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,38553,2523,0.93 [0.83-1.04],0.2109639311210146
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",50154,125,1.49 [0.91-2.43],0.1136761331007427
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Hernia,48693,6532,0.90 [0.84-0.97],0.0042162714309286
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Impacted teeth,51804,104,1.09 [0.63-1.91],0.7504616044497169
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Impaction of intestines,36709,113,1.17 [0.69-1.99],0.5658468290657483
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Inguinal hernia,43978,1817,0.80 [0.70-0.91],0.0006052181446757
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",42369,208,0.78 [0.53-1.15],0.2087855407631338
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,36790,194,1.37 [0.92-2.06],0.1242400455464765
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Intestinal malabsorption,48775,290,1.08 [0.77-1.50],0.6550292358342985
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,37710,1114,0.95 [0.80-1.13],0.5740164143897994
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,51915,741,0.87 [0.71-1.07],0.1934868798090889
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,49943,1522,0.99 [0.86-1.14],0.88125431130229
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,50446,2025,0.98 [0.86-1.11],0.733738282174557
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Oesophageal obstruction,39299,379,0.78 [0.59-1.05],0.0971216492023181
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Oesophagitis,40132,1212,0.96 [0.82-1.13],0.6040141803342935
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,51872,274,0.95 [0.67-1.33],0.7469127504385911
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,42298,137,1.02 [0.63-1.64],0.9368118247823356
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,39322,2726,0.90 [0.81-1.00],0.0491512327684712
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,48456,562,0.98 [0.77-1.24],0.8734113432905886
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,48211,317,1.06 [0.78-1.46],0.7052536772702205
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of intestine,40094,3498,0.92 [0.84-1.01],0.0822672526567469
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of intestines,47940,11344,0.94 [0.90-1.00],0.0335053809867488
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,49932,413,0.95 [0.72-1.25],0.6992632308262093
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of liver,51420,1391,0.96 [0.83-1.12],0.6147275035311333
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,40256,1336,0.96 [0.82-1.12],0.6012656843846413
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of pancreas,48198,304,1.39 [1.01-1.91],0.042510848350601
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,51656,826,0.89 [0.73-1.08],0.22721253194784
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,40835,1915,1.00 [0.88-1.13],0.9549457855039382
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,50853,2368,0.94 [0.84-1.06],0.3062108675373088
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,50393,377,1.07 [0.80-1.42],0.6485377320748744
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,40052,3456,0.96 [0.87-1.06],0.398251705702667
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),42973,4053,0.97 [0.89-1.06],0.4746325700653971
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,50229,200,1.15 [0.78-1.70],0.4871457530007608
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,50200,1779,1.02 [0.90-1.17],0.727703226166142
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",37288,692,0.94 [0.75-1.16],0.5431882889223942
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,51770,132,1.27 [0.78-2.08],0.342948628561303
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,37579,983,0.98 [0.82-1.18],0.8452027338723477
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",48786,301,1.35 [0.98-1.86],0.0648587541599436
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Recurring oral aphthae,51949,112,1.13 [0.67-1.92],0.6476366236308814
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,50025,236,1.13 [0.78-1.63],0.5167484253157979
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Toxic colitis,48534,113,1.45 [0.85-2.45],0.1688332202689164
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,39457,537,0.91 [0.72-1.17],0.4711858096211859
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Ulcerative colitis,48742,321,1.08 [0.79-1.49],0.6121355370787066
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",48688,267,1.03 [0.73-1.46],0.8458484027912443
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Umbilical hernia,42710,549,1.04 [0.82-1.32],0.7436491552564183
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,36948,352,0.93 [0.69-1.26],0.6385016991602483
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Ventral hernia,42685,524,0.81 [0.63-1.03],0.087616752107707
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Volvulus,36755,159,0.80 [0.51-1.25],0.329463750175041
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,51809,600,1.12 [0.89-1.41],0.3355000231380713
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,51323,144,0.68 [0.43-1.09],0.1074392762358078
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,47847,322,0.90 [0.65-1.23],0.5020072982992132
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,50692,1412,1.05 [0.90-1.21],0.5345629831325354
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",49631,351,0.89 [0.66-1.20],0.4481946633221987
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,48350,825,0.94 [0.78-1.14],0.5516320821017271
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,51357,558,0.83 [0.66-1.06],0.1346246875987919
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,51768,969,0.91 [0.76-1.09],0.3012465764722792
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,50896,97,0.65 [0.37-1.14],0.1351101681490699
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,48844,6447,1.00 [0.93-1.07],0.9808889238568254
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,51064,902,0.79 [0.66-0.95],0.0138727477633932
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,50797,635,0.79 [0.63-0.98],0.0349401934790922
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,51184,1904,1.01 [0.89-1.15],0.8728713160816483
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",51939,110,0.85 [0.49-1.45],0.5432541965789494
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,47639,114,1.93 [1.15-3.26],0.0132738583312568
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,50268,106,1.15 [0.67-1.97],0.603893615063714
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,51336,537,0.87 [0.68-1.10],0.2413770080934165
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,48439,914,1.12 [0.93-1.35],0.2224296704727744
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,47655,130,1.10 [0.67-1.80],0.7040693808325567
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,51797,167,1.62 [1.06-2.47],0.0271247886233523
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,49660,380,0.85 [0.64-1.13],0.2546681400671629
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,51566,387,0.80 [0.60-1.07],0.1285352681523397
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,50928,129,1.33 [0.82-2.16],0.2480689670125054
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,47659,134,1.05 [0.65-1.71],0.8342682928388713
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,50808,3283,1.04 [0.95-1.15],0.4051245437802502
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",48516,991,1.17 [0.98-1.40],0.0811540227467029
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,47663,138,0.98 [0.61-1.58],0.930467866119524
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,51792,613,0.82 [0.65-1.02],0.0774500676796533
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,50938,139,1.15 [0.72-1.85],0.5516665330768408
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,51680,501,0.82 [0.64-1.05],0.1127890710401055
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,51863,654,1.19 [0.95-1.48],0.1274252195758417
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,47778,253,0.89 [0.62-1.27],0.503733793506369
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,48064,539,1.07 [0.84-1.36],0.5903292166758001
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,51843,634,1.17 [0.94-1.46],0.1648177035572191
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",48004,479,0.95 [0.74-1.23],0.7129287363543503
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,51911,281,1.53 [1.10-2.13],0.0116996284998106
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,44583,222,1.01 [0.69-1.48],0.9502000956713156
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,47291,11332,0.96 [0.91-1.01],0.0910186672466588
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,44458,8499,0.95 [0.89-1.01],0.0841846076288852
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,44514,153,0.74 [0.47-1.16],0.1873053804375141
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,45062,308,1.30 [0.95-1.79],0.1057693502257843
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,45111,357,1.43 [1.07-1.93],0.0166180054379531
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,51473,185,1.55 [1.03-2.33],0.0346402770404387
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",44954,200,0.71 [0.48-1.06],0.0936588514384434
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,38233,2274,0.94 [0.83-1.06],0.3124013953047004
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",51698,379,1.06 [0.79-1.41],0.6956949274340954
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,45650,896,0.85 [0.71-1.03],0.0991462168112993
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,43911,14574,0.92 [0.88-0.97],0.0010738178236363
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,47984,233,0.76 [0.52-1.09],0.1365741602799945
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,44665,304,0.88 [0.64-1.21],0.4201141963307001
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,45505,1144,1.03 [0.87-1.22],0.7016144771613009
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,50098,5344,0.93 [0.86-1.01],0.0708225394894923
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,44909,548,0.91 [0.71-1.15],0.4326611743686313
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,44801,440,0.88 [0.67-1.15],0.3487997262419936
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,44631,270,1.01 [0.72-1.43],0.9471894009534652
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,50675,141,1.07 [0.66-1.72],0.7866323069082762
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,39360,3401,0.92 [0.84-1.01],0.0955190834795701
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,37172,1213,1.07 [0.92-1.25],0.3824034068644691
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",51818,1196,1.06 [0.90-1.24],0.4943518158263277
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,36111,152,0.96 [0.60-1.53],0.8685399670666342
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),36623,664,1.13 [0.91-1.42],0.266346362419856
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,44973,612,0.76 [0.61-0.96],0.0203157084584198
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,37242,1283,1.10 [0.94-1.29],0.2261228236519554
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,44866,112,0.79 [0.46-1.35],0.3894159970949765
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,46015,1261,0.96 [0.82-1.13],0.631863001856817
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,45364,610,1.01 [0.80-1.27],0.9290387692251744
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,37156,1197,1.14 [0.97-1.34],0.1223714570700358
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,44523,162,1.28 [0.82-2.00],0.2687305559768906
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",44486,125,1.08 [0.65-1.78],0.7760772868684851
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,47898,147,1.13 [0.72-1.77],0.6064189511866354
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,51190,3439,0.98 [0.89-1.08],0.7345776504479578
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,50000,2249,0.99 [0.88-1.12],0.9330653008641664
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",51688,907,1.01 [0.84-1.21],0.9407388418632512
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,40966,5007,0.92 [0.85-1.00],0.0514995324772996
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,36086,127,0.86 [0.52-1.42],0.5484442730726627
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,44547,186,1.28 [0.85-1.93],0.236171148316443
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,36057,98,2.18 [1.25-3.79],0.0058851597775454
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),36211,252,0.95 [0.66-1.37],0.7949367614540819
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,48235,484,0.99 [0.77-1.28],0.961488560076643
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,48518,767,1.06 [0.86-1.30],0.5852318952582485
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,51906,201,1.01 [0.68-1.49],0.9775418829471376
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",48374,3620,1.00 [0.91-1.09],0.9577544639916296
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,44564,203,1.05 [0.71-1.57],0.7951565087073897
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),36239,280,1.07 [0.76-1.51],0.6941975107396603
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,46214,1460,1.00 [0.87-1.16],0.9505449297005152
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,40288,4329,1.02 [0.94-1.11],0.6604078486274685
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,50724,190,1.16 [0.77-1.75],0.4696071293408163
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,51933,138,0.68 [0.42-1.10],0.1155565512959011
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,44525,164,0.66 [0.43-1.03],0.0658411663016478
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",46873,2512,1.01 [0.90-1.13],0.8565656389246343
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,44541,180,0.97 [0.64-1.47],0.8798297428207228
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,39205,3246,0.85 [0.77-0.94],0.0012740376079174
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,47975,224,0.80 [0.55-1.16],0.2338048552199476
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,44470,109,1.50 [0.87-2.59],0.142174717671126
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,45074,320,0.85 [0.62-1.16],0.3134824924597602
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,45471,1110,1.09 [0.92-1.29],0.3161951668255036
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,51250,716,1.04 [0.84-1.29],0.6996986523428542
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,45900,1146,1.09 [0.93-1.29],0.2979323694498977
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,51712,881,1.02 [0.85-1.24],0.8076899951471659
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,51928,108,0.89 [0.52-1.53],0.6692110338401078
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,44744,383,0.89 [0.67-1.19],0.4450622188945858
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,41139,1521,1.11 [0.96-1.28],0.1496172442266209
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,45535,1174,1.03 [0.87-1.21],0.760170471143461
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],44820,459,0.86 [0.66-1.12],0.2712527972676455
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",36068,109,0.98 [0.57-1.69],0.9479807395487192
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,40939,4980,0.87 [0.81-0.95],0.0009469473116047
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,37277,1318,0.91 [0.78-1.06],0.2408309300056098
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,51002,468,1.02 [0.78-1.32],0.8921535398343733
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",51838,133,1.16 [0.71-1.89],0.5467673513504197
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",47608,103,1.32 [0.77-2.26],0.317200090592429
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,36100,141,0.64 [0.40-1.03],0.0684792810591977
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,44957,203,1.10 [0.74-1.63],0.6298443883668293
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,36878,919,0.95 [0.79-1.15],0.6056203625872829
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,44982,621,0.79 [0.63-0.99],0.0368816829979154
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,45264,510,1.05 [0.82-1.34],0.7159697510775951
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,45133,379,0.76 [0.57-1.01],0.0615867057377172
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,40645,115,0.67 [0.40-1.14],0.1416915650818519
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",51936,116,1.01 [0.60-1.70],0.9671534533993226
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,45552,1191,0.80 [0.68-0.94],0.0066815832174402
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],50722,188,1.12 [0.74-1.70],0.5946826718434649
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,49538,5177,0.98 [0.91-1.06],0.6617216193425259
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",44624,263,0.91 [0.64-1.29],0.5976987211025482
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,45842,1088,1.15 [0.97-1.37],0.0964779310617716
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,49141,470,0.82 [0.64-1.07],0.1432697930994165
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,45169,415,1.08 [0.82-1.42],0.6060657940818523
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,47881,3127,0.97 [0.87-1.07],0.5108337294198174
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,46807,2053,1.01 [0.89-1.14],0.8678109933735616
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],44470,109,1.24 [0.73-2.12],0.4309884149430329
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,50803,269,0.85 [0.60-1.20],0.3591276398201409
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,44689,328,1.26 [0.92-1.72],0.1508418477673496
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,44513,152,1.24 [0.78-1.96],0.3561720444569863
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),36076,117,1.05 [0.62-1.76],0.8652992835718055
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Acute renal failure,49858,3166,1.69 [1.53-1.87],3.8497349059432586e-25
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20977,102,1.02 [0.58-1.79],0.9506890219784412
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27314,111,0.82 [0.48-1.42],0.4829090464825655
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,51329,651,0.98 [0.79-1.21],0.827591621142568
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,50848,170,0.70 [0.46-1.07],0.1002753064697013
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,49770,3078,3.77 [3.42-4.16],1.4018826676575567e-157
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,51542,165,11.10 [7.81-15.78],4.64086628562216e-41
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,51476,604,1.32 [1.05-1.65],0.0161225754223447
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Cystitis,45772,469,0.87 [0.67-1.13],0.3102150693465496
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Dialysis,46847,155,24.42 [17.60-33.88],1.532665312413595e-81
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,22659,3341,0.99 [0.90-1.09],0.8379866260446542
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27547,344,0.96 [0.71-1.31],0.80361201400616
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Endometriosis,21058,183,1.25 [0.82-1.91],0.2935441886114849
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",21276,401,0.76 [0.57-1.01],0.0618539351592974
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21900,1025,0.67 [0.56-0.80],1.4160892431010106e-05
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,43384,10799,1.11 [1.05-1.17],0.000145776087397
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,51544,167,5.92 [3.98-8.81],1.480510587989711e-18
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Hydrocele,19526,208,0.67 [0.46-0.99],0.0432757694741547
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,46677,589,1.35 [1.07-1.71],0.011188820822679
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,21943,2625,0.99 [0.89-1.10],0.860559697361599
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27463,408,0.89 [0.67-1.18],0.4171446834543157
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19552,234,0.83 [0.58-1.19],0.3085835113895742
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Irregular menses,27554,131,0.74 [0.44-1.22],0.2313739384601584
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21183,308,0.79 [0.57-1.10],0.1634843803641995
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,45463,160,0.83 [0.53-1.30],0.4184617737207232
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,23380,2505,0.83 [0.74-0.93],0.0011110300874596
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,19426,108,0.71 [0.42-1.20],0.1983853222638616
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,21020,145,0.88 [0.55-1.42],0.6109895227576312
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",51945,130,1.05 [0.64-1.71],0.8453532603607423
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",51955,133,0.58 [0.36-0.94],0.0273686741254563
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,49856,4553,0.99 [0.91-1.07],0.736624834998671
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,46747,1444,0.90 [0.78-1.05],0.1726403671407971
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,27323,120,1.01 [0.60-1.71],0.961202412834574
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,51833,961,1.70 [1.42-2.03],5.6143115511700915e-09
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19629,311,1.05 [0.77-1.44],0.7562625932357399
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19600,282,0.90 [0.65-1.25],0.5171970502911132
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,19553,235,0.91 [0.64-1.30],0.6089019607545365
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,51894,137,0.62 [0.39-1.01],0.0538246473606451
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,48813,3510,1.05 [0.95-1.15],0.316914737777309
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,27267,212,0.90 [0.61-1.33],0.5989124626691831
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,21033,158,0.70 [0.44-1.10],0.1236426813536785
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",21254,379,0.94 [0.70-1.26],0.6749931153504689
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20991,116,0.56 [0.33-0.96],0.0341488189224089
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,21083,208,0.61 [0.41-0.91],0.0162324812465652
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,46773,685,1.49 [1.20-1.85],0.0003347625055121
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,51192,320,2.02 [1.48-2.74],7.64769762313176e-06
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,21192,317,1.08 [0.79-1.50],0.6240187028488473
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20984,109,0.67 [0.39-1.15],0.1482105029858049
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21534,659,0.84 [0.67-1.05],0.1182059857400628
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,21037,162,0.92 [0.59-1.45],0.7242839561982559
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21476,601,0.75 [0.60-0.95],0.0161139437446304
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,51475,98,2.79 [1.61-4.84],0.0002731247918402
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19585,267,1.04 [0.74-1.45],0.8396946386037641
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,51468,5380,1.93 [1.79-2.09],1.2660265320884998e-64
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",46328,240,1.37 [0.94-1.98],0.0981737094674403
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,46953,261,3.68 [2.62-5.17],5.2745653946171933e-14
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,50793,115,1.23 [0.73-2.05],0.4385344781084214
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Urethral stricture,45746,443,1.12 [0.86-1.46],0.4042565962046942
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Urolithiasis,51483,805,0.95 [0.78-1.16],0.62996207537827
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Uterine polyps,21019,144,0.74 [0.46-1.19],0.2142578557999254
